27 related articles for article (PubMed ID: 27460074)
1. m
Benavides-Serrato A; Saunders JT; Kumar S; Holmes B; Benavides KE; Bashir MT; Nishimura RN; Gera J
Cancer Lett; 2023 May; 562():216178. PubMed ID: 37061119
[TBL] [Abstract][Full Text] [Related]
2. Isoform-Directed Control of c-Myc Functions: Understanding the Balance from Proliferation to Growth Arrest.
Kubickova A; De Sanctis JB; Hajduch M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139353
[TBL] [Abstract][Full Text] [Related]
3. Regulation of eIF4E guides a unique translational program to control erythroid maturation.
Forester CM; Oses-Prieto JA; Phillips NJ; Miglani S; Pang X; Byeon GW; DeMarco R; Burlingame A; Barna M; Ruggero D
Sci Adv; 2022 Dec; 8(51):eadd3942. PubMed ID: 36563140
[TBL] [Abstract][Full Text] [Related]
4. The Translational Landscape Revealed the Sequential Treatment Containing ATRA plus PI3K/AKT Inhibitors as an Efficient Strategy for AML Therapy.
Wang K; Ou Z; Deng G; Li S; Su J; Xu Y; Zhou R; Hu W; Chen F
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365147
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer.
Vittori C; Jeansonne D; Yousefi H; Faia C; Lin Z; Reiss K; Peruzzi F
Cancer Cell Int; 2022 May; 22(1):204. PubMed ID: 35642054
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis.
Bera A; Lewis SM
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517298
[TBL] [Abstract][Full Text] [Related]
7. Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer.
Vaklavas C; Blume SW; Grizzle WE
Transl Oncol; 2020 Feb; 13(2):452-470. PubMed ID: 31911279
[TBL] [Abstract][Full Text] [Related]
8. The Untranslated Regions of mRNAs in Cancer.
Schuster SL; Hsieh AC
Trends Cancer; 2019 Apr; 5(4):245-262. PubMed ID: 30961831
[TBL] [Abstract][Full Text] [Related]
9. Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.
Sriram A; Bohlen J; Teleman AA
EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30224410
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical Translation Initiation in Eukaryotes.
Kwan T; Thompson SR
Cold Spring Harb Perspect Biol; 2019 Apr; 11(4):. PubMed ID: 29959190
[TBL] [Abstract][Full Text] [Related]
11. More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer.
Lacerda R; Menezes J; Romão L
Cell Mol Life Sci; 2017 May; 74(9):1659-1680. PubMed ID: 27913822
[TBL] [Abstract][Full Text] [Related]
12. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells.
Vaklavas C; Grizzle WE; Choi H; Meng Z; Zinn KR; Shrestha K; Blume SW
Tumour Biol; 2016 Oct; 37(10):13247-13264. PubMed ID: 27460074
[TBL] [Abstract][Full Text] [Related]
13. Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition.
Vaklavas C; Zinn KR; Samuel SL; Meng Z; Grizzle WE; Choi H; Blume SW
Oncol Rep; 2018 Jun; 39(6):2482-2498. PubMed ID: 29620220
[TBL] [Abstract][Full Text] [Related]
14. Small molecule inhibitors of IRES-mediated translation.
Vaklavas C; Meng Z; Choi H; Grizzle WE; Zinn KR; Blume SW
Cancer Biol Ther; 2015; 16(10):1471-85. PubMed ID: 26177060
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma.
Holmes B; Lee J; Landon KA; Benavides-Serrato A; Bashir T; Jung ME; Lichtenstein A; Gera J
J Biol Chem; 2016 Jul; 291(27):14146-14159. PubMed ID: 27226604
[TBL] [Abstract][Full Text] [Related]
16. Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES.
Blume SW; Jackson NL; Frost AR; Grizzle WE; Shcherbakov OD; Choi H; Meng Z
Exp Mol Pathol; 2010 Jun; 88(3):341-52. PubMed ID: 20233590
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma.
Benavides-Serrato A; Saunders JT; Holmes B; Nishimura RN; Lichtenstein A; Gera J
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948038
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
